NDC 25682-020 - hLAL rDNA Construct in SBC LAL-C Chickens
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 25682-020
- Package NDCs from labels
- 25682-020-01
- Manufacturer
- Alexion Pharmaceuticals, Inc.
- Effective date
- 2024-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| hLAL rDNA Construct in SBC LAL-C Chickens | Alexion Pharmaceuticals, Inc. | 2024-10-22 | INTENTIONAL ANIMAL GENOMIC ALTERATION LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 25682-020-01 | hLAL rDNA Construct in SBC LAL-C Chickens | 1 [arb'U] in 1 NOT APPLICABLE | NOT APPLICABLE | 1 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STRENSIQ | ASFOTASE ALFA | Alexion Pharmaceuticals, Inc. | 3387574f-5eaa-4501-a71d-4cbfbd563031 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | Alexion Pharmaceuticals, Inc. |